首页> 外文OA文献 >Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells
【2h】

Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells

机译:抗肿瘤细胞毒性T淋巴细胞的融合 人树突状细胞和乳腺癌细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have reported that fusions of murine dendritic cells (DCs) and murine carcinoma cells reverse unresponsiveness to tumor-associated antigens and induce the rejection of established metastases. In the present study, fusions were generated with primary human breast carcinoma cells and autologous DCs. Fusion cells coexpressed tumor-associated antigens and DC-derived costimulatory molecules. The fusion cells also retained the functional potency of DCs and stimulated autologous T cell proliferation. Significantly, the results show that autologous T cells are primed by the fusion cells to induce MHC class I-dependent lysis of autologous breast tumor cells. These findings demonstrate that fusions of human breast cancer cells and DCs activate T cell responses against autologous tumors.
机译:我们已经报道鼠类树突状细胞(DCs)和鼠类癌细胞的融合逆转了对肿瘤相关抗原的无反应性,并诱导已建立的转移的排斥。在本研究中,与原代人乳腺癌细胞和自体DC融合。融合细胞共表达肿瘤相关抗原和DC衍生的共刺激分子。融合细胞还保留了DC的功能效能,并刺激了自体T细胞增殖。有意义的是,结果表明融合细胞启动了自体T细胞,以诱导MHC I类依赖的自体乳腺肿瘤细胞裂解。这些发现证明人乳腺癌细胞和DC的融合激活了针对自体肿瘤的T细胞应答。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号